Related Experiment Video
Updated: Jun 20, 2026
06:42
Murine Skin Transplantation
Published on: January 16, 2008
22.9K
Review article: Emerging issues in pediatric skin of color, Part 2
Krystal N Mitchell1, Yong Kwang Tay2, Candrice R Heath3
1Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, NY, USA.
Pediatric Dermatology
|October 28, 2021
Summary
Pediatric dermatology for skin of color addresses unique diagnostic and therapeutic challenges in children with increased pigmentation. This article highlights inflammatory conditions, melanocytic disorders, and hypopigmented mycosis fungoides in diverse pediatric populations.
Area of Science:
- Pediatric Dermatology
- Dermatology for Skin of Color
Background:
- Pediatric skin of color encompasses diverse racial and ethnic groups with increased pigmentation.
- Diagnosing common dermatological conditions can be challenging due to pigmentation, hair practices, and disease demographics.
- Certain conditions present differently or are more prevalent in children with darker skin tones.
Purpose of the Study:
- To address the nuances of inflammatory skin diseases in pediatric patients of color.
- To discuss specific considerations for melanocytic disorders in pediatric skin of color.
- To review hypopigmented mycosis fungoides in the context of pediatric dermatology for skin of color.
Main Methods:
- Literature review focusing on inflammatory skin diseases, melanocytic disorders, and specific conditions like hypopigmented mycosis fungoides.
- Analysis of clinical presentation variations based on skin pigmentation.
- Examination of therapeutic differences related to skin color in pediatric dermatology.
Main Results:
- Inflammatory skin diseases exhibit distinct clinical appearances and require tailored management in pediatric skin of color.
- Melanocytic disorders present unique diagnostic challenges and considerations in children with increased pigmentation.
- Hypopigmented mycosis fungoides requires specific diagnostic and management approaches in pediatric patients of color.
Conclusions:
- Understanding the specific challenges in pediatric dermatology for skin of color is crucial for accurate diagnosis and effective treatment.
- Variations in presentation and management strategies are essential for addressing dermatological conditions in diverse pediatric populations.
- This article provides insights into key areas of pediatric skin of color dermatology, including inflammatory conditions, melanocytic disorders, and hypopigmented mycosis fungoides.
Related Concept Videos
01:30Assessment of Airway, Skin Color, and Use of Accessory Muscles
A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Introduction
The initial evaluation of a patient's respiratory system...
01:14Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...